NOTICES
Notice No. 20230106-32 Notice Date 06 Jan 2023
Category Company related Segment SME
Subject Migration of Equity Shares of Gian Life Care Limited from BSE SME Platform to BSE Mainboard Platform
Attachments Annexure II.pdf ; Annexure I.pdf ;
Content

Trading Members of the Exchange are hereby informed that effective from Tuesday, January 10, 2023, the equity shares of Gian Life Care Limited which are already listed under BSE SME Platform will now be migrated & admitted to dealings on the Mainboard Platform in the list of 'B' Group.

<_o3a_p>

Name of the Company<_o3a_p>

Gian Life Care Limited<_o3a_p>

Registered Office<_o3a_p>

7/216 (6) Swaroop Nagar Kanpur-208002, Uttar Pradesh, India<_o3a_p>

Tel. No.- +91-0512-2531860<_o3a_p>

E-Mail: info@gianpathlabs.com<_o3a_p>

Website:www.gianpathlab.com<_o3a_p>
Securities<_o3a_p>

1,03,41,524 Equity Shares of Rs.10/- each fully paid-up <_o3a_p>

Distinctive numbers<_o3a_p>

1 to 10341524<_o3a_p>

Market Lot<_o3a_p>

One Share<_o3a_p>

Scrip Code<_o3a_p>

542918<_o3a_p>

Abbreviated Name on BOLT System<_o3a_p>

GIANLIFE<_o3a_p>

Scrip ID on BOLT System<_o3a_p>

GIANLIFE<_o3a_p>

ISIN No.<_o3a_p>

INE063601012<_o3a_p>

<_o3a_p><_o3a_p>

1. Trading Members may note that as per the guidelines issued by SEBI dated February 16, 2000, securities of the company will only be traded in Dematerialized form. Trades effected in this scrip will be in unit market lot (i.e., one share).<_o3a_p>

2. The audited financial result of the Company for the half year ended September 30, 2022, is enclosed as Annexure I.<_o3a_p>

<_o3a_p>

3. A copy of the shareholding pattern as on December 31, 2022, submitted by the company is enclosed as Annexure II.<_o3a_p>

<_o3a_p>

4. The company's financial year ending is March 31.<_o3a_p>

<_o3a_p><_o3a_p>

5. Subsequent to the migration, the Market Maker to the Company in the BSE SME Platform, M/s. Shreni Shares Private Limited will cease to continue as Market Maker to the Company<_o3a_p>

<_o3a_p><_o3a_p>

6. The address of the Registrar and Transfer Agent of the Company is given below:<_o3a_p>

Cameo Corporate Services Limited<_o3a_p>

Submaramanian Building<_o3a_p>

1 Club House Road, Chennai, Tamil Nadu,600002<_o3a_p>

Tel: 022-49186200<_o3a_p>

Contact Person: Ms. Kalpana Sridhar<_o3a_p>

E-mail: cameo@cameoindia.com,investor@cameoindia.com<_o3a_p>

<_o3a_p><_o3a_p>

7. In case members require any clarifications on the subject matter of this Notice, they may please contact any of the following:<_o3a_p>

<_o3a_p>

A) At the Company:<_o3a_p>

<_o3a_p>

Mr. Vanshul Asnani<_o3a_p>

Company Secretary & Compliance Officer<_o3a_p>

Address:<_o3a_p>

7/216 (6) Swaroop Nagar Kanpur-208002, Uttar Pradesh, India<_o3a_p>

Tel. No.- +91-0512-2531860<_o3a_p>

E-Mail: info@gianpathlabs.com<_o3a_p>

Website:www.gianpathlab.com<_o3a_p>
B) At the Exchange:<_o3a_p>

<_o3a_p>

Raghavendra Bhat<_o3a_p>

Associate Manager <_o3a_p>

<_o3a_p>

<_o3a_p>

Tel.: 022-22728915<_o3a_p>

<_o3a_p>

<_o3a_p>

<_o3a_p><_o3a_p>

Rupal Khandelwal<_o3a_p>

Assistant General Manager<_o3a_p>

Friday, January 06, 2023<_o3a_p>

<_o3a_p><_o3a_p>

Attachments

Disclaimer

BSE Ltd. published this content on 06 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 January 2023 13:37:46 UTC.